Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Heinz-Taheny KM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
MacLachlan TK; Novartis Institutes for Biomedical Research, Cambridge, MA, 01239, USA. Electronic address: Timothy.maclachlan@novartis.com., Price S; Charles River Laboratories, 15 Worman's Mill Court, Suite I, Frederick, MD, 21701, USA., Cavagnaro J; Access BIO, LC, Boyce, VA, 22620, USA., Andrews L; AbbVie, 100 Research Dr, Worcester, MA, 01520, USA., Blanset D; Boehringer Ingelheim, 900 Ridgebury Road, Ridgefield, CT, 06877, USA., Cosenza ME; MEC Regulatory & Toxicology Consulting, LLC, Moorpark, CA, 93021, USA., Dempster M; GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA, 19426, USA., Galbreath E; Drug Safety Research and Evaluation, Takeda US, Inc., Cambridge, MA, USA., Giusti AM; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Zurich, Switzerland., Heinz-Taheny KM; Toxicology and Pathology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Fleurance R; UCB BioPharma SRL, B-1420, Braine L'Alleud, Belgium., Sutter E; Novartis Institutes for Biomedical Research, Basel, Switzerland., Leach MW; Drug Safety Research and Development, Pfizer, Inc, 300 Technology Square, Cambridge, MA, 02139, USA.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2021 Apr; Vol. 121, pp. 104872. Date of Electronic Publication: 2021 Jan 22.
Autor:
Harlan SM; 1 Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA., Heinz-Taheny KM; 1 Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA., Overstreet JM; 2 Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Breyer MD; 1 Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.; 3 Department of Medicine, Indiana University, Indianapolis, Indiana, USA., Harris RC; 2 Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Heuer JG; 1 Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2018 Dec; Vol. 46 (8), pp. 991-998. Date of Electronic Publication: 2018 Nov 05.
Autor:
Heinz-Taheny KM; 1 Eli Lilly and Company, Indianapolis, Indiana, USA., Harlan SM; 1 Eli Lilly and Company, Indianapolis, Indiana, USA., Qi Z; 1 Eli Lilly and Company, Indianapolis, Indiana, USA., Heuer JG; 1 Eli Lilly and Company, Indianapolis, Indiana, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2018 Dec; Vol. 46 (8), pp. 970-975. Date of Electronic Publication: 2018 Sep 13.
Autor:
Harlan SM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Heinz-Taheny KM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Sullivan JM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Wei T; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Baker HE; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Jaqua DL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Qi Z; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Cramer MS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Shiyanova TL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Breyer MD; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana., Heuer JG; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana jheuer@lilly.com.
Publikováno v:
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2018 Feb; Vol. 29 (2), pp. 477-491. Date of Electronic Publication: 2017 Oct 23.
Autor:
Heuer JG; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana heuer_josef_g@lilly.com., Harlan SM; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Yang DD; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Jaqua DL; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Boyles JS; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Wilson JM; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Heinz-Taheny KM; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Sullivan JM; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Wei T; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Qian HR; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Witcher DR; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Breyer MD; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
Publikováno v:
American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2017 Jun 01; Vol. 312 (6), pp. F951-F962. Date of Electronic Publication: 2017 Mar 01.
Autor:
Bellinger MA; Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Bean JS; Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Rader MA; Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Heinz-Taheny KM; Investigational Pathology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Nunes JS; Covance Laboratories, Greenfield, Indiana, United States of America., Haas JV; Statistics-Discovery/Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Michael LF; Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Rekhter MD; Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
Publikováno v:
PloS one [PLoS One] 2014 Apr 02; Vol. 9 (4), pp. e93297. Date of Electronic Publication: 2014 Apr 02 (Print Publication: 2014).
Autor:
Ma L; Eli Lilly and Company, Indianapolis, IN, USA., Clayton JR, Walgren RA, Zhao B, Evans RJ, Smith MC, Heinz-Taheny KM, Kreklau EL, Bloem L, Pitou C, Shen W, Strelow JM, Halstead C, Rempala ME, Parthasarathy S, Gillig JR, Heinz LJ, Pei H, Wang Y, Stancato LF, Dowless MS, Iversen PW, Burkholder TP
Publikováno v:
Blood cancer journal [Blood Cancer J] 2013 Apr 12; Vol. 3, pp. e109. Date of Electronic Publication: 2013 Apr 12.
Autor:
Engle SK; Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, USA. Englesk@lilly.com, Jordan WH, Pritt ML, Chiang AY, Davis MA, Zimmermann JL, Rudmann DG, Heinz-Taheny KM, Irizarry AR, Yamamoto Y, Mendel D, Schultze AE, Cornwell PD, Watson DE
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2009 Aug; Vol. 37 (5), pp. 617-28. Date of Electronic Publication: 2009 Jun 23.